Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Chemicals

Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for agrochemicals, medical, glass, cosmetics, etc. Industries. The company was founded in 2003 and is based in Chennai, India.

Revenue projections:

Revenue projections for ACI
Revenue projections for ACI

The projected decline in ACI's revenues compared to last year is expected to make investors cautious. A drop in revenue often has a direct negative effect on the company's bottom line, signaling potential challenges that could undermine investor confidence and reduce overall profitability.

Financial Ratios:

currentRatio 1.212000
forwardPE 15.946468
debtToEquity 24.128000
earningsGrowth -0.741000
revenueGrowth -0.129000
grossMargins 0.940550
operatingMargins 0.069430
trailingEps 8.670000
forwardEps 33.625000

ACI's current ratio of 1.212 means the company has enough liquidity to meet its short-term debt obligations. With sufficient cash reserves and current assets, ACI can comfortably cover its liabilities, reflecting a strong financial outlook.
ACI's Forward PE ratio is in a good range, reflecting a reasonable balance between stock price and earnings. The stock is not overpriced, leaving room for growth, which suggests potential for investors looking to capitalize on future value appreciation.
ACI's low Debt-to-Equity ratio indicates the company is not over-leveraged. This suggests a balanced financial structure with limited reliance on debt, which reduces financial risk and enhances its stability, making ACI's financial position more secure and appealing to investors.
Archean Chemical Industries Limited's low earnings and revenue growth suggest that the company may see declining profits. This indicates potential financial challenges ahead, and could lead to a more cautious outlook from investors.
ACI's negative gross and operating margins suggest that the company is struggling to cover its production and operating costs, leading to losses. This reflects a weakened financial state and potential difficulties in sustaining profitability.
ACI's forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights ACI's potential for increased earnings and a stronger financial performance in the upcoming year.

Price projections:

Price projections for ACI
Price projections for ACI

The price of Archean Chemical Industries Limited has often been situated close to the lower end of projections. This consistent trend may signal difficulties for the company in achieving investor expectations for future performance.

Insider Transactions:

Insider Transactions for ACI
Insider Transactions for ACI


1 separate purchases of ACI stock were made, while market price was at 627.5499877929688 per share.There were no buy transactions during the given timeframe.Archean Chemical Industries Limited's current price levels are marked by increased selling, which could indicate further price drops. If this selling trend persists, the stock may continue to decline as investor confidence weakens.

Recommendation changes over time:

Recommendations trend for ACI
Recommendations trend for ACI


Analysts have shown a sell bias toward Archean Chemical Industries Limited, recommending caution for investors. To make sound decisions, it's important to consider a broader base of market indicators, providing a fuller picture of Archean Chemical Industries Limited's outlook and avoiding overreliance on one specific viewpoint.